The Biology of HNF1A and How It's Diagnosed

To understand HNF1A-related hyperinsulinism, it helps to think of the pancreas as a high-tech factory. In a typical body, this factory releases some basal insulin and increases secretion as glucose rises. However, in children with this condition, a “blueprint” error in the HNF1A gene causes the factory to release insulin inappropriately even when blood sugar is low ^[1][2].

The Role of the HNF1A Gene

The HNF1A gene provides instructions for making a protein called a transcription factor ^[1]. You can think of a transcription factor as a “master switch” that turns other genes on or off ^[3]. In the beta cells of the pancreas—the cells responsible for making insulin—HNF1A controls the switches for genes involved in sensing glucose and controlling the machinery that actually pumps insulin out into the bloodstream ^[3][4].

When there is a deficiency or “error” in HNF1A, the beta cells become dysregulated. While scientists are still researching the exact “why,” the result in infancy is clear: the beta cells become overactive and release excessive amounts of insulin ^[2][5]. This excess insulin acts like a key that stays turned in the “on” position, forcing the body to use up sugar until levels become dangerously low ^[6].

The ‘Critical Sample’: Catching the Moment

Diagnosing this condition requires precise timing. Doctors must collect what is known as a critical sample—a series of blood tests taken under medical supervision at the exact moment your child is experiencing a low blood sugar event (hypoglycemia) ^[7][8]. Families should never withhold feeds or deliberately induce a dangerous low to obtain one.

Waiting for a “low” is necessary because blood sugar and insulin are dynamic; testing them when blood sugar is normal might not show the problem. The goal of the critical sample is to see how the body is reacting to the crisis ^[8].

Key Biomarkers: Reading the Pattern

In the critical sample, doctors look for a specific pattern among four key markers:

• Insulin and C-peptide: C-peptide is a byproduct created when the body makes insulin ^[9]. Because the body clears insulin very quickly, C-peptide often provides a more stable and accurate “footprint” of how much insulin the pancreas is actually making ^[10][11].
• Beta-hydroxybutyrate (Ketones): When blood sugar is low, a healthy body should start burning fat for energy, which creates ketones ^[12]. High insulin levels actively block the production of ketones ^[13].
• Free Fatty Acids: Similarly, insulin prevents the body from breaking down fats into free fatty acids ^[9].

The Hyperinsulinism Pattern: If the blood test shows low blood sugar combined with low ketones and low fatty acids, it is a strong sign that insulin is present and “acting” on the body, even if the insulin level itself looks low on paper ^[9][12].

Why “Undetectable” Doesn’t Mean “Normal”

One of the most confusing parts of this diagnosis is that a child can have hyperinsulinism even if their insulin level is reported as “low” or “undetectable” during a low blood sugar episode ^[7][9]. This happens for several reasons:

• Rapid Clearance: The body can clear insulin from the blood in just a few minutes ^[11].
• Sample Quality: Depending on the assay, if the blood sample was slightly damaged (hemolysis) during collection, it can artificially lower the insulin reading ^[11].
• Assay Limits: Some laboratory tests (assays) are not sensitive enough to pick up small amounts of insulin that are still enough to cause problems for an infant ^[14][15].

To support the diagnosis when insulin levels are unclear, doctors may use a glucagon response test ^[9]. Glucagon is a hormone that tells the liver to release stored sugar. If giving glucagon causes a significant jump in blood sugar (often defined as an increase of 30 mg/dL or more), it supports the diagnosis by showing that insulin has been “trapping” sugar in the liver, which is a hallmark of hyperinsulinism ^[9][16].

Confirming with Genetic Testing

While the critical sample tells doctors what is happening (hyperinsulinism), genetic testing tells them why ^[1]. By analyzing your child’s DNA, specialists can identify the specific change in the HNF1A gene ^[1][17].

This confirmation is vital because it distinguishes HNF1A-related cases from other forms of congenital hyperinsulinism ^[1]. Knowing the genetic cause helps your care team predict how the condition might change as your child grows and allows for the testing of parents or siblings who may carry the same gene ^[1][18]. A “Variant of Uncertain Significance” (VUS) or negative result does not establish the disease; diagnosis relies on a pathogenic variant interpreted in clinical context.